Market Place
Sourcing Support
PMV Pharma Reports Q3 2024 Financial Results
07 Nov 2024 //
GLOBENEWSWIRE
PMV Pharmaceuticals Updates on PYNNACLE Clinical Trial
23 Oct 2024 //
GLOBENEWSWIRE
PMV Pharma Reports Q2 2024 Results And PYNNACLE Trial Update
08 Aug 2024 //
GLOBENEWSWIRE
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June
30 May 2024 //
GLOBENEWSWIRE
PMV Pharmaceuticals Q1 2024 Results And Highlights
09 May 2024 //
GLOBENEWSWIRE
PMV Pharma Phase I Data of Rezatapopt Featured in Presentation
18 Mar 2024 //
GLOBENEWSWIRE
PMV lays off 30% to fund ph. 2 trial of solid tumor drug
19 Jan 2024 //
FIERCE BIOTECH
PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586
11 Oct 2023 //
GLOBENEWSWIRE
PMV Pharmaceuticals Reports Second Quarter 2023 Financial Results
09 Aug 2023 //
GLOBENEWSWIRE
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in March
28 Feb 2023 //
GLOBENEWSWIRE
PMV Pharmaceuticals to Participate in Annual Evercore Conference
22 Nov 2022 //
GLOBENEWSWIRE
PMV Pharmaceuticals Appoints Industry Veteran Dr. Carol Gallagher to BOD
04 Nov 2022 //
GLOBENEWSWIRE
PMV Pharmaceuticals Reports Second Quarter 2022 Financial Results
09 Aug 2022 //
GLOBENEWSWIRE
PMV Pharma Announces Trial Collaboration with Merck for PC14586 + KEYTRUDA
18 Jul 2022 //
GLOBENEWSWIRE
PMV Pharma to Participate in the Goldman Sachs Global Healthcare Conference
08 Jun 2022 //
GLOBENEWSWIRE
PMV Pharma Initial PC14586 PI Data Presented at ASCO
07 Jun 2022 //
GLOBENEWSWIRE
PMV Pharma Initial PC14586 Phase 1 Data Presented at ASCO
07 Jun 2022 //
PRESS RELEASE
PMV Pharmaceuticals Announces Initial PC14586 PI Data at ASCO 2022
26 May 2022 //
GLOBENEWSWIRE
PMV Pharmaceuticals Reports First Quarter 2022 Financial Results
10 May 2022 //
GLOBENEWSWIRE
PMV Pharmaceuticals to Present PC14586 Phase 1 Clinical Data at 2022 ASCO
27 Apr 2022 //
GLOBENEWSWIRE
PMV Pharma Reports Q4 and Full Year 2021 Financial Results
01 Mar 2022 //
GLOBENEWSWIRE
PMV Pharma to Participate in the 42nd Annual Cowen Health Care Conference
28 Feb 2022 //
GLOBENEWSWIRE
PMV Pharma to Present at the Evercore ISI 4th Annual HealthCONx Conference
22 Nov 2021 //
GLOBENEWSWIRE
PMV Pharma Reports Q3 2021 Financial Results and Corporate Highlights
12 Nov 2021 //
GLOBENEWSWIRE
PMV Pharma Strengthens Board of Directors with Appointment of Dr. Charles Baum
06 Apr 2021 //
BIOSPACE
PMV Pharmaceuticals Announces Presentation of PC14586 Preclinical Data
10 Mar 2021 //
GLOBENEWSWIRE
PMV Pharma Doses First Patient in Phase 1/2 Study of PC14586
23 Nov 2020 //
GLOBENEWSWIRE
PMV Pharma Granted FDA Fast Track Designation of PC14586
13 Oct 2020 //
GLOBENEWSWIRE
PMV Pharma Announces Pricing of Initial Public Offering
25 Sep 2020 //
BIOSPACE
PMV Pharmaceuticals Seeks $125 Million To Enter Trials
21 Sep 2020 //
SEEKING ALPHA
